Entrada Therapeutics
TRDA
TRDA
55 hedge funds and large institutions have $411M invested in Entrada Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 5 closing their positions.
Holders
55
Holders Change
-1
Holders Change %
-1.79%
% of All Funds
0.88%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
4
Increased
19
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
| $19.2K | 1,212 | – | – |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $15.8K | 1,003 | +409 | +69% |
|
53
Osaic Holdings
Scottsdale,
Arizona
| $4.74K | 300 | – | – |
|
54
Citigroup
New York
| $490 | 31 | -6,632 | -100% |
|
55
Russell Investments Group
London,
United Kingdom
| $142 | 9 | -6,744 | -100% |
|
56
Millennium Management
New York
| – | – | -18,298 | Closed |
|
57
Man Group
London,
United Kingdom
| – | – | -14,466 | Closed |
|
58
Marshall Wace
London,
United Kingdom
| – | – | -11,312 | Closed |
|
59
Lazard Asset Management
New York
| – | – | -2,417 | Closed |
|
60
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | – | -200 | Closed |
|
|
CFGS
61
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|